Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Drug Research
Drug Discovery & Development
Return to: PBR Home | Drug Research | Drug Discovery & Development

Drug Discovery & Development

University of Dundee secures grant to discover new antibacterial drugs University of Dundee in the UK has been awarded almost £1m to boost efforts to identify new new antibiotics to tackle bacterial infections.
Drug Research > Drug Discovery & Development > News
Ignyta to explore strategic options for cancer candidate taladegib Ignyta is exploring strategic options for taladegib and has entered into an amended and restated license, development and commercialization agreement with Eli Lilly and Company for the taladegib oncology program.
Drug Research > Drug Discovery & Development > News BioLineRx acquires UK cancer immunotherapeutics company Agalimmune Clinical-stage biopharmaceutical firm BioLineRx has purchased Agalimmune, a private UK-based company with an anti-cancer immunotherapy platform.
Drug Research > Drug Discovery & Development > News
See more Drug Discovery & Development news

Latest Drug Discovery & Development News and Insight

View all Drug Discovery & Development news or find news targeted to your interests
GSK, Regeneron to mine gene data from 500000 volunteer participants in UK
Regeneron Pharmaceuticals announced a major research initiative among the Regeneron Genetics Center (RGC), U.K. Biobank and GSK to generate genetic sequence data from the 500,000 volunteer participants in the U.K. Biobank resource.
Drug Research > Drug Discovery & Development > News
Pierre Fabre, H-Immune partner on immuno-oncology therapeutics
French pharma Pierre Fabre has entered into a strategic research partnership with H-Immune to develop immuno-oncology therapeutics using the latter’s technology platform to generate lead candidates of fully human antibodies.
Drug Research > Drug Discovery & Development > News
X-Chem, Ono to collaborate on multi-target drug discovery
X-Chem, a biotechnology firm focused on developing novel small molecule therapeutics by applying its innovative drug discovery platform, has entered into a partnership with Ono Pharmaceutical.
Drug Research > Drug Discovery & Development > News
SalvaRx to invest in Rift Biotherapeutics
SalvaRx, a subsidiary of SalvaRx Group, has agreed to invest in Delaware-based biotechnology company Rift Biotherapeutics which focuses on the development of antibodies for use in oncology.
Drug Research > Drug Discovery & Development > News
Circassia signs deal for US rights to two AstraZeneca COPD drugs
By PBR Staff Writer
UK-based Circassia Pharmaceuticals has agreed to pay up to $230m for certain US commercial rights for Tudorza and Duaklir, two drugs developed by AstraZeneca to treat chronic obstructive pulmonary disease (COPD).
Drug Research > Drug Discovery & Development > News
FlexyCUBE Product Catalog
| By SYSTAG
SYSTAG - Your Partner in Chemical Development
Drug Research > Drug Discovery & Development > White Papers
FlexyCUBE - for parallel process optimisation
The Modular Tool Tailored to Suit any Laboratory Automation Needs
Drug Research > Drug Discovery & Development > Products
ePAT logging - online trend & data capture
ePAT – for various reactions and processes Quick, easy, inexpensive
Drug Research > Drug Discovery & Development > Products
FlexyPAT - Covers all your automation needs
FlexyPAT – Reactors can be automated individually Functional – cost-optimised – user-friendly
Drug Research > Drug Discovery & Development > Products
Cell Medica raises £60m to advance multiple cancer programmes
Cellular immunotherapy company, Cell Medica has secured £60m in a Series C financing round with participation from existing investors Touchstone Innovations, funds managed by Woodford Investment Management, and funds managed by Invesco Perpetual.
Drug Research > Drug Discovery & Development > News
View all Drug Discovery & Development news or find news targeted to your interests